cAMPfield Therapeutics

cAMPfield Therapeutics, Inc. was formed as a California corporation on June 1, 2026, in San Diego. The filing was made without a registered agent classification on record, and no annual report or EIN is on file yet. The company operates in the biotechnology sector, specifically developing inflammatory and immunology therapeutics, and appears to be a pre-commercial biotech firm based on its $180M Series A funding round, which suggests a planned launch and significant investor backing. We estimate revenue in the $1M-$10M range, likely from grants or early-stage partnerships, and an employee count of 26 to 100, typical for a drug development company at this stage. Its footprint is brick-and-mortar, requiring physical lab and office space in San Diego. The company has a modern website, first recorded here on June 12, 2026, just 11 days after filing, which aligns with a recent launch. Notably, the domain registration and website build appear contemporary, with a modern JS framework and responsive design, and the copyright year is 2026. The identity matches news about a San Diego biotech raising $180M in Series A funding, reinforcing its credibility as a real, operating business.